TY - JOUR T1 - Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients With Locally Advanced Breast Cancer and Partial Response After Neoadjuvant Chemotherapy JF - In Vivo JO - In Vivo SP - 2489 LP - 2494 DO - 10.21873/invivo.12529 VL - 35 IS - 4 AU - MARCO PELLICCIARO AU - MARCO MATERAZZO AU - CHIARA BUONOMO AU - GIANLUCA VANNI Y1 - 2021/07/01 UR - http://iv.iiarjournals.org/content/35/4/2489.abstract N2 - Background/Aim: Axillary reverse mapping (ARM) aims to identify and preserve arm drainage in order to prevent lymphedema following axillary lymph node dissection. Oncological-safety and feasibility are still debated, especially in patients with locally-advanced breast cancer (LABC). We report the first case of the AXMAP 1.0 study performed in our Institution. Patients and Methods: A 52-year-old patient with a triple-negative LABC and partial response to neoadjuvant chemotherapy underwent axillary lymph-node dissection using fluorescence ARM. Results: Two lymph-nodes draining the ipsilateral upper arm were identified and were not preserved due to suspicion of malignancy. Pathological examination confirmed the presence of malignancy in both lymph nodes. Conclusion: Further studies should be designed in order to validate the oncological safety of this technique, especially in patients with LABC requiring neoadjuvant chemotherapy. ER -